Cargando…

BDP1 as a biomarker in serous ovarian cancer

BACKGROUND: TFIIIB, an RNA polymerase III specific transcription factor has been found to be deregulated in human cancers with much of the research focused on the TBP, BRF1, and BRF2 subunits. To date, the TFIIIB specific subunit BDP1 has not been investigated in ovarian cancer but has previously be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cabarcas‐Petroski, Stephanie, Olshefsky, Gabriella, Schramm, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028122/ https://www.ncbi.nlm.nih.gov/pubmed/36305848 http://dx.doi.org/10.1002/cam4.5388

Ejemplares similares

BDP1 Alterations Correlate with Clinical Outcomes in Breast Cancer
por: Cabarcas-Petroski, Stephanie, et al.
Publicado: (2022)

MAF1 is a predictive biomarker in HER2 positive breast cancer
por: Cabarcas-Petroski, Stephanie, et al.
Publicado: (2023)

A meta-analysis of BRF2 as a prognostic biomarker in invasive breast carcinoma
por: Cabarcas-Petroski, Stephanie, et al.
Publicado: (2020)

Biomarker discovery process at binomial decision point (2BDP): Analytical pipeline to construct biomarker panel
por: Chakraborty, Nabarun, et al.
Publicado: (2023)

Induction of proto-oncogene BRF2 in breast cancer cells by the dietary soybean isoflavone daidzein
por: Koo, Jana, et al.
Publicado: (2015)

The Putative Bromodomain Protein PfBDP7 of the Human Malaria Parasite Plasmodium Falciparum Cooperates With PfBDP1 in the Silencing of Variant Surface Antigen Expression
por: Quinn, Jennifer E., et al.
Publicado: (2022)

Gene Expression and DNA Methylation in Human Papillomavirus Positive and Negative Head and Neck Squamous Cell Carcinomas
por: Hinić, Snežana, et al.
Publicado: (2022)

Structural insights into acetylated histone ligand recognition by the BDP1 bromodomain of Plasmodium falciparum
por: Singh, Ajit Kumar, et al.
Publicado: (2022)

Molecular mechanisms of Bdp1 in TFIIIB assembly and RNA polymerase III transcription initiation
por: Gouge, Jerome, et al.
Publicado: (2017)

Comment on Li et al. BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. Diagnostics 2021, 11, 2364
por: Schramm, Laura
Publicado: (2022)

Linkage Study and Exome Sequencing Identify a BDP1 Mutation Associated with Hereditary Hearing Loss
por: Girotto, Giorgia, et al.
Publicado: (2013)

Differential expression of the TFIIIB subunits Brf1 and Brf2 in cancer cells
por: Cabarcas, Stephanie, et al.
Publicado: (2008)

RNA polymerase III transcription in cancer: the BRF2 connection
por: Cabarcas, Stephanie, et al.
Publicado: (2011)

TFIIIB Subunit Bdp1 Participates in RNA Polymerase III Transcription in the Protozoan Parasite Leishmania major
por: Román-Carraro, Fiordaliso C., et al.
Publicado: (2019)

BDP/FF NEXThaler to Improve Asthma Control Status in the Real World: The NEWTON Study
por: Braido, Fulvio, et al.
Publicado: (2023)

Importance of Potential New Biomarkers in Patient with Serouse Ovarian Cancer
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2021)

Tissue Biomarkers in Prognostication of Serous Ovarian Cancer following Neoadjuvant Chemotherapy
por: Khandakar, Binny, et al.
Publicado: (2014)

AKR1B1 as a Prognostic Biomarker of High-Grade Serous Ovarian Cancer
por: Hojnik, Marko, et al.
Publicado: (2022)

An apicomplexan bromodomain protein, TgBDP1, associates with diverse epigenetic factors to regulate essential transcriptional processes in Toxoplasma gondii
por: Fleck, Krista, et al.
Publicado: (2023)

Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer
por: Győrffy, Balázs
Publicado: (2023)

Identification of an Individualized Prognostic Biomarker for Serous Ovarian Cancer: A Qualitative Model
por: Luo, Fengyuan, et al.
Publicado: (2022)

Integrated Analysis To Identify Molecular Biomarkers Of High-Grade Serous Ovarian Cancer
por: Si, Manfei, et al.
Publicado: (2019)

Crystallographic characterization of the metal–organic framework Fe(2)(bdp)(3) upon reductive cation insertion
por: Biggins, Naomi, et al.
Publicado: (2020)

Human Maf1 negatively regulates RNA Polymerase III transcription via the TFIIB family members Brf1 and Brf2
por: Rollins, Janet, et al.
Publicado: (2007)

Screening and Identification of Biomarkers in Ascites Related to Intrinsic Chemoresistance of Serous Epithelial Ovarian Cancers
por: Huang, He, et al.
Publicado: (2012)

Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer
por: Dutt, Mriga, et al.
Publicado: (2023)

Discovery of a biomarker candidate for surgical stratification in high-grade serous ovarian cancer
por: Lu, Haonan, et al.
Publicado: (2021)

Identification of Prognosis Biomarkers for High-Grade Serous Ovarian Cancer Based on Stemness
por: Wang, Zhihang, et al.
Publicado: (2022)

Prediction of chemo-response in serous ovarian cancer
por: Gonzalez Bosquet, Jesus, et al.
Publicado: (2016)

AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer
por: Ardizzoia, Alessandra, et al.
Publicado: (2023)

Notch signaling in serous ovarian cancer
por: Groeneweg, Jolijn W, et al.
Publicado: (2014)

Kallikrein family proteases KLK6 and KLK7 are potential early detection and diagnostic biomarkers for serous and papillary serous ovarian cancer subtypes
por: Tamir, Ayala, et al.
Publicado: (2014)

Testing for NRAS Mutations in Serous Borderline Ovarian Tumors and Low-Grade Serous Ovarian Carcinomas
por: Sadlecki, Pawel, et al.
Publicado: (2018)

Low-grade Serous Ovarian Carcinoma
por: Ricciardi, Enzo, et al.
Publicado: (2018)

KLF7: a new candidate biomarker and therapeutic target for high-grade serous ovarian cancer
por: De Donato, Marta, et al.
Publicado: (2020)

LINE-1 ORF1p as a candidate biomarker in high grade serous ovarian carcinoma
por: Sato, Sho, et al.
Publicado: (2023)

Mutational heterogeneity in non-serous ovarian cancers
por: Teer, Jamie K., et al.
Publicado: (2017)

Fallopian tube secreted protein affects ovarian metabolites in high grade serous ovarian cancer
por: Bergsten, Tova M., et al.
Publicado: (2022)

Proteome profiling of low grade serous ovarian cancer
por: zadeh fakhar, Haniyeh Bashi, et al.
Publicado: (2019)

TCR Clonality and Genomic Instability Signatures as Prognostic Biomarkers in High Grade Serous Ovarian Cancer
por: Lecuelle, Julie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vtf42l00flsegsrcqccshk0sig